(Q51732617)

11 April 2018

http://europepmc.org/abstract/MED/24859907

title

Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumonia. (English)

1 reference

11 April 2018

http://europepmc.org/abstract/MED/24859907

main subject

pneumonia

0 references

Pseudomonas aeruginosa

0 references

1 reference

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24859907%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Bruno François

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24859907%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

J-L Pagani

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24859907%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

author name string

Y-A Que

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24859907%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

H Lazar

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24859907%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

M Wolff

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24859907%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

P-F Laterre

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24859907%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

E Mercier

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24859907%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

J Garbino

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24859907%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

J-P Revelly

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24859907%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

E Mus

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24859907%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

A Perez

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24859907%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

M Tamm

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24859907%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Q Lu

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24859907%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

J Chastre

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24859907%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

P Eggimann

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24859907%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

publication date

24 May 2014

1 reference

11 April 2018

http://europepmc.org/abstract/MED/24859907

published in

European Journal of Clinical Microbiology & Infectious Diseases

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24859907%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24859907%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24859907%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

page(s)

1861-1867

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24859907%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10096-014-2156-1

4 June 2020

exact match

0 references

cites work

Infection control in the ICU.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2156-1

International study of the prevalence and outcomes of infection in intensive care units

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2156-1

Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2156-1

Risk factors for development of intestinal colonization with imipenem-resistant Pseudomonas aeruginosa in the intensive care unit setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2156-1

The effect of late-onset ventilator-associated pneumonia in determining patient mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2156-1

Pseudomonas aeruginosa ventilator-associated pneumonia: comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2156-1

Impact of multidrug resistance on Pseudomonas aeruginosa ventilator-associated pneumonia outcome: predictors of early and crude mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2156-1

Other therapeutic modalities and practices: implications for clinical trials of hospital-acquired or ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2156-1

Polyclonal immunoglobulins and hyperimmune globulins in prevention and management of infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2156-1

Prophylactic intravenous administration of standard immune globulin as compared with core-lipopolysaccharide immune globulin in patients at high risk of postsurgical infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2156-1

Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2156-1

Monoclonal antibodies in infectious diseases: clinical pipeline in 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2156-1

Human monoclonal antibodies against Pseudomonas aeruginosa lipopolysaccharide derived from transgenic mice containing megabase human immunoglobulin loci are opsonic and protective against fatal pseudomonas sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2156-1

Preclinical in vitro and in vivo characterization of the fully human monoclonal IgM antibody KBPA101 specific for Pseudomonas aeruginosa serotype IATS-O11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2156-1

Anti-Pseudomonas aeruginosa serotype O11 LPS immunoglobulin M monoclonal antibody panobacumab (KBPA101) confers protection in a murine model of acute lung infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2156-1

O-Antigen Serotypes and Type III Secretory Toxins in Clinical Isolates of Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2156-1

Relative contribution of three main virulence factors in Pseudomonas aeruginosa pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2156-1

Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2156-1

Pharmacokinetics and safety of panobacumab: specific adjunctive immunotherapy in critical patients with nosocomial Pseudomonas aeruginosa O11 pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2156-1

APACHE II: a severity of disease classification system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2156-1

Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2156-1

Antibiotic exposure and resistance development in Pseudomonas aeruginosa and Enterobacter species in intensive care units

21 January 2018

1 reference

12 December 2020

Autoantibodies against bactericidal/permeability-increasing protein (BPI-ANCA) in cystic fibrosis patients treated with azithromycin

1 reference

12 December 2020

Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis

1 reference

12 December 2020

Serotyping and virulence factors of Pseudomonas aeruginosa clinical isolates

1 reference

12 December 2020

Safety and pharmacokinetics of an anti-PcrV PEGylated monoclonal antibody fragment in mechanically ventilated patients colonized with Pseudomonas aeruginosa

1 reference

12 December 2020

Cytokine modifiers: pipe dream or reality?

1 reference

12 December 2020

Ventilator-associated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa: prevalence, incidence, risk factors, and outcomes

1 reference

12 December 2020

Immunoprotective human monoclonal antibodies against five major serotypes of Pseudomonas aeruginosa

1 reference

12 December 2020

Association patterns of Pseudomonas aeruginosa clinical isolates as revealed by virulence traits, antibiotic resistance, serotype and genotype

1 reference

12 December 2020

10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America

1 reference

12 December 2020

The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine

1 reference

12 December 2020